Objectives: To analyzethe necessity andpotential usefulnessofacomputerizedphysicianorderentry(CPOE) system in supportingthe writingofpharmacotherapeutic recommendationsindischarge letters. Methods: Systematic analysis of drug recommendationsindischarge letters of ahospital providingtertiarycare,structuredinterviews with in-hospital prescribers, andfocus groups with general practitioners who admit patients to thishospital. Results: We analyzed 1800 randomly selected discharge letters, 1205ofwhich contained pharmacotherapeutic recommendations. Thefrequencies, structure,and quality of theserecommendationsvaried considerablybetween departments.Nearly 16% of the recommendationscontainedbothproprietary(brand) andnon-proprietarynames(activeingredient).Interviewed clinicians expressedinterestinCPOE systems that checkfor contraindicationsand interactionsbetween drugs, suggest cheaperproducts, andautomatically insert active ingredients when omitted.The focus group sessions confirmedthatthe pharmacotherapeutic recommendationsincurrent discharge lettersdo noteffectively support daily clinicalpractice. Conclusions: Documentingactive ingredients as well as brandnamesindrug therapy recommendationsis currently notpart of clinical practice.Computerized decision support can helptooptimise thestructure and communicationoftherapeutic information across interfaces and canbeaquality factor with considerable influenceonprocess quality, outcome quality, and costs of cooperative patientcare.
Introduction
Computerized physician orderentry (CPOE) is increasingly discussed in them edical informatics community.F ew articles focus on topics of order entryliketest ordering [1, 2] , or quality aspects liket he timeliness of results [2] .The majority of articles dealwith medication [3] [4] [5] and discuss thet opico f patientsafety [6] . Butespecially theroleof CPOE in patientsafety is currentlythe subject to debate. While for example in pediatric care ac onsiderable reductiono fa dverse drug events by 40.9%,ofprescriptionerrors by 99.4%,a nd of rule violations of 97.9% after implementationo faC POE system has been observed [ 7] ,i na nother pediatric settingC POE implementationc oincided with increased mortality [8] . Indeed,h igh ratesofadverse events maystill occur after CPOE implementation [ 9] and thes ources of errors in thec omputer-supported medicationp rocess are numerous [5,1 0] .T his mayexplainwhy negative emotionstowards CPOE can frequentlyb eo bserved [11] . Nevertheless, it is reasonable that CPOE systems can contribute to ahigher quality of them edication processi ft heya re welldesigned and carefullya pplied.D ecision support fordrugselection, dose adjustment and monitoring is necessary [9] to maximize effectivenessand safety.
Wit ht he growing trend of treating patients in acooperative manner ('cooperative care')another aspect of process quality for medication emerges: In the Germand rug market we arec onfronted with al arge number (about 56,000) of proprietary medicinalp roducts. These medicationsi nclude both so called 'originator products' whichr equireaf ull dossier for marketing authorization,a nd their 'generic' formulations (i.e. competitor medicinalp roducts containing the samea ctivei ngredient that have been marketed aftere xpiryo ft he patent of the originator). Generalp ractitioners, whosepatients typically obtain their medication directly from af ull-service pharmacy, prescribe brands from the whole market.H ospital pharmacies, however, are smallerinscaleand arenot able to have this variety of productsinstock. The typical tertiary careh ospital provides a( often electronic)c atalogue that includesa pproximately 2000 to 3000 products. Due to this difference, challenges for the prescribing physicians maya rise when out-patients fromg eneral practitionersb ecome in-patients of hospitals whichonlyhaverestricted local formularies(see Fig. 1 , cf.also [12] ). As aconsequence, in many instances medication is switchedt oa nother proprietary productwhenapatientalreadyondrugtherapyisadmitted to ahospital.Asanexample, apatient with congestiveheartfailuremay be maintainedo nt hreed rugs whichh ave been prescribedbyhis generalpractitioner. Uponadmission aclinicianmay have to exchange severaldrugs eitherbecause agiven productisnot availableinthe hospital pharmacy or because of achange in the patient's ongoing medical problem. He mayalsoadd drugs to treat the acute illness prompting the admission. Hence, multiple changesindrug therapy will occur, some of whicha re caused by the differences between the respective formularies. Because of the complexity of the prescriptionp rocess, every change also holds the risk of introducing an error.I nG ermany,w henapatienti sd ischargedf rom the hospital, the patient's physicianw rites ad ischarge letter.T his letter summarizes the reasons for hospitalization,t he interventions,a nd results and findings during the hospital stay,and gives recommendationsfor further therapy to the generalpractitioner (cf. e.g. [13] ) whoisin charge of follow-up. Patients area dditionally givenp rescriptions for their discharge medicationsatthe time of discharge. After discharget he clinicianh as to decide whetherthe patientshould resume treatment with the medication administeredb efore hospitalization and/or continue the medication administeredduring the hospital stay. Because ambulatoryd rugt herapy is covered by arestrictedbudgetdedicated to the individual generalp ractitioner,g eneral practitionershaveadirect incentive to favor well-priced drugs.S inceah ospital formulary is rathers mall andc osts areo ptimized for in-hospitalp atients,c onflicts between dischargemedication and(affordable)a mbulatoryt reatments aref requent [14] . Hence,combination therapy afterdischarge tends to be modified with switchesto genericb rands or cheaper me-toop reparations (competitor drugs that mayl ack significant therapeuticadvantages),ormay even be discontinued [14] [15] [16] [17] .
Similarp roblems also arisew henp rescriptions or recommendations onlyspecify atherapy'sactiveingredients, such as occurs in countries liket he UnitedS tateso rG reat Britain. Fore xampleo nt he one hand additives(e.g. sulfites) maycause toxicreactions in sensitive patientsortheycan also lead to interactions with other drugs (e.g. cremophor).O nt he other hand there are products for whichd osing informationr elates to the activeagent as free base (e.g. lithium, phenytoin), as opposed to other products that refer to thesalt. In thelattercase thesamestrength of twobrands maycontaingrosslydivergent amountso fa ctivec ompound resultingi n considerable changes in exposure.
tions for patients with renali nsufficiency, mini expert systemsf or drug selection in particularp atients,a nd an error-tolerant search feature.W ew antedt oe xtend the functionality of AiDKlinik so thati tc ould also assist physicians in the compilation of discharge medication orders,a nd to tailor thisf unctionality to include the particular needsofinterns andresidents. Before developing such asystem, we needed to evaluate both sidesofthe in-patient/out-patient continuityofcareinterface. Thegoalofthis investigation wast oa nswert he following questions:
• Howoftenare drug recommendationsin dischargeletters formulatedasanactive ingredient or brandname? • Does this share differinthe various departments of al arge teaching hospital providing tertiarycare? • Do pharmacotherapeutic recommendationsi nd ischarge letters opposet he respective standardsingeneral practice? • What aret he requirements fora ne lectronic system thatsupports the prescription process in discharge letters while considering the needso fp hysicians on both sidesofthe interface?
Methods
To analyzethe different questionsweundertookthreeindependent investigations, combined their results in ajoint analysis, anddeTo improvedrugprescription at the interface between in-patient anda mbulatory care, both factors relating to activei ngredient as well as brand name should be consideredtodulyaccount for characteristicsof the individual patient(Table1). It therefore appearscritical to always recommend active ingredients as well as appropriateb rand names. Giventhe size of the market andthe frequencyo fc hanges( particularlyi np ricing), it is aconsiderableeffortfor the clinician to find andcompile allinformation for acomprehensive drug recommendation (althoughthis is of major relevancefor effectiveness, patientsafety, andprocess quality in generalpractice).
Indeed,i tw ould facilitate prescriptions in generalp racticea nd reduceb reaksa nd switchesinpharmacotherapy if prescribers in hospitals would consider the particularitieso ft he ambulatorys etting.T os upport the whole process of drug andd oses election,anelectronic drug information system coupled to knowledge bases for dosei ndividualization (AiDKlinik )has been running at the HeidelbergUniversity Hospitalsince 2003 [18] . It contains detailed information of allproducts on the Germandrugmarket, including the Germansummaryofproduct characteristicsa nd publicp rices. Drugs availablei nt he hospital formulary are highlighted anda lwaysd isplayedf irst (www.aidklinik.de).F urther characteristics ofAiDKlinik include:electronic prescribing with interfaces to the local hospital information systems, dosing recommenda- veloped alistofsystem requirements andan architecture for acomputerized tooltosupportt he prescription in dischargel etters. Thefollowing three methods were applied: manual analysis of dischargeletters,structured interviews with clinicians,a nd focus group interviews with generalpractitioners.
2.1A nalysisofDischarge Letters
We randomlys elected 1800 discharge letters of ah ospital providing tertiaryc are dating from the monthb efore the project started. The sample wasweighedaccording to the numberofin-patientcases of individuald epartments of the hospital. Fore ach drug in each dischargel etterw ea ssessed whetherthe following information on drug sent to the interviewedclinicians,and feedback wasrequested.
2.3F ocus GroupInterviews
Five focus group interviews were prepared andconducted with 25 generalpractitioners of the region by the Department of General Practicea nd Health ServicesR esearch according to existing guidelines [ 19] . In accordancew ith Tang andc o-workers [ 20] a focus group wasd efineda s" aq ualitative data collection methodu sed to obtain the views and experience of agroup of people in ad efinedt opic area" [20] . Severalg roup discussions arerecommended to receive reliabledataonaresearch topic.Focus groups as aresearch methodare becoming increasingly popular in health research.The group interviews conducted in thiss tudyf ocused on the communication of pharmacotherapy at the interface between generalp ractitionersa nd hospital residents. Thef ocus groups were audio andv ideot aped,t ranscribed, anda nalyzed using the software AT LAS.ti( AT LAS.ti-t he Knowledge Wo rkbench. 2005).
Results
Partso ft hese data have previouslyb een published in abstract form [21] .
3.1A nalysisofDischarge Letters
We analyzed dischargeletters fromeach department involved in in-patient care(atotal of 1800 letters). Of these, 1205 discharge letters containedp harmacotherapeutic recommendations (66%) for follow-up treatment. For1 88 dischargel etters (15.6% of 1205)the drug recommendationscontained the name of allactiveingredients.This percentage variedamongthe departments with ar ange between 0a nd 46% (mean ±s tandard deviation:16.6±13.8%).
The1205 dischargeletters containedinformation on 5792 drugs,which is an averageo f4 .7 drugs perd ischarge letter that containedpharmacotherapeutic recommentherapy wasl istedu nambiguously:b rand name,a ctivei ngredient, strength, andd osageschedule.
2.2S tructured Interviewswith Clinicians
Each department in this hospitalnominates asenior physicianasadelegatetothe hospital'sd rugc ommittee,w hich dealsw ith all matters of drug useinthe hospital.Inorder to collect the views of the delegates, we first developed ag uideline for performing a structuredi nterviewa nd then performed a test interviewwith an independent clinician. Afteroptimization,the interviews were performed, interviewr esult summariesw ere Information on the completeness of the dosing regimen is showni nF igure 2. For 81.7% of alldrugrecommendations, the information on dosage peradministration was unambiguous.T his variedi nt he departments between 20 and1 00% (76.1± 21.3%). Thenumber of administrationsper dayw as describedi n5 5.6% of the recommendationsb yadetailed schemef or drug administration,a nd an additional 30.5% were accompaniedbyanunambiguous free text description for administration.
3.2S tructured Interviewswith Clinicians
Therei sat ypicalp rocess for writing discharge letters in Germany. First, the clinician whot reated the patient dictatest he letter andt hent he secretarial stafft ranscribest he dictation. Afterwards there is a correction cycles tarting with the resident, laterinvolving asenior physicianand often the head of the clinic,a nd with afinalr eviewperformedbythe clinicianwho treated the patient. When the letterissigned by all responsible physicians,itissenttothe general practitioner whow ill continue the patient'sa mbulatoryc are. Ac opyi sa lso archived in the patient record. The members of the hospitald rugc ommittee whor epresented 12 departments treating in-patients andw riting discharge letters reported the following supporting measuresi np lace at their departments:d epartmentalg uidelines for structure andlayout (12 =100%), integration of patient data fromthe localhospital information system (12 =100%), useof standard text elements (auto text, 5= 41.6%), andt emplate letters for frequent mendations generallyd on ot consider the budgetc onstraints for drug prescription in out-patientc are. They assumedt hath ospitalsh avec ontractsw ith pharmaceutical companiess ot hate xpensived rugs can be obtainedb elow the sales prices of ap ublic pharmacy. Theg eneral practitionerse xpressed thatp rescribing afterd ischarge would be easier to themi ft he activei ngredients were consistentlym entioned in allpharmacotherapeutic recommendations. Theselection of asuitable drug wasidentified as aproblem, whereas dosing of drugs wasn ot mentioned as such by the focus group members. Thea vailability of the discharge letter immediatelya fterp atients ared ischargedf rom hospitalw as am ajor issue in allfocus group interviews.Amajor requirement identifiedinall focusgroup interviews wasthatthe primarycarephysician receivesaf ax 24 hours prior to discharge thatc ontains the recommended pharmacotherapy,and indicates the appropriateclinician to contacti fq uestionsa rise afterd ischarge.I na ddition, unnecessarys witches could be avoided anda cceptanceo ft reatment changesw ould be increased if the reasons for changesinmedication were also given. Of further help would be if information giventothe patientatdischarge were printed(andtherefore better legible)instead of handwritten. Them embers of the focus groups also expressed thatt heyw ould appreciateifdischarge letters were writtenaccording to the SOAP structure (Subjective findings, Objectivef indings, Assessment, Plan,cf. e.g. [23] ). diagnoses (2 =16.6%). Thedepartments reported that dischargel etters were written eitherinthe evening before discharge (three departments,2 5%), immediatelya fterd ischarge (eight departments,6 6.7%), or,i n the case of one department, at al ater date. Sevend epartments (58.3%)r eported using the brand name as the main drug information while listing the activeingredient in bracketsa ftert he brand name. In three (25%) departments the opposite wasr eported. Twod epartments typically recommended in mostcases the drugsthatthe patient wastaking before his stay in the hospital. Eightd epartments (66.7%)u sed their electronic intraneti nformation system as an information sourcef or pharmacotherapeuticrecommendations, and eight departments used ap aper-based comprehensive Germandrugmarketbook [22] . These two groups partiallyo verlap, with sixd epartments (50%)using both. Otherinformation sources likeg uidelines or colleaguesw ere onlymentioned in isolatedcases.
Additional useful supportf eaturesf or electronic drug information systemsm entioned by the clinicians included:Alertsfor contraindications andd rugi nteractions, automatic displayo fl ow-priced alternatives, automatic entryofthe activeingredient, as well as comprehensive andup-todate drug information.
3.3F ocus GroupInterviews
Thef ocus group interviewees mentioned thatpharmacotherapeutic discharge recom- Fig. 2 Fraction of 5792 drugs mentionedin1205 dischargeletters with information on dosage regimen (number of administrationsper day). In an unambiguous scheme it wouldbenoted by "1-0-1-0" thatone tablet shouldbeadministered in the morning and one in the evening.
Discussion

4.1D iscussion of Results
Ourr esultsh avec onfirmedt hat pharmacotherapeutic recommendations at theinterfacebetween primaryand secondarycare are af requent source of problemsi nG ermany caused by ap rocess whichisn ot harmonized and farf rom beinga djusted to the needs of either party involved. Forclinicians it is at ime-consumingt ask to translatet he current in-hospitaltherapyintoaprescription meetingthe expectations of thecolleague in an entirelydifferent setting. In Germany, for general practitioners,t he drug recommendations in discharge summaries can induce an economic burdeni ft reatment costs exceed thec onstitutedb udget.F inally,t he seacteristicswhich are related to theproductor to theactiveingredient and whichw ouldbe useful features of future decision support systems.
Ac ommon weakness of the communication of drug therapy in this setting is the lack of using ac ommon thesaurusf or the drugs needed by the patient. Sincef ormulariesonboth sidesofthe interface between in-patient ando ut-patientc ared ifferc onsiderablyinthe number of brands,but differ significantlyless with respect to the number of activeingredients,increasing the proportion of recommendationsthatspecify active ingredients as well as brand names would likely help fill this communication gap. A possiblestandardization effortwhich is deduced from the results of this study andfulfils the requirements of Germanlegislation is summarized in Figure 3 . To supportt he prescription process at the interface between in-patient ando ut-patientc area ccording to the suggestion in Figure 3a CPOE systemneedstobeintegrated into the local information system,and requires decision supporta nd an option for long-term archiving.Inordertocope with the sizeable amount of activeingredients,additives, and brand names,d ifferent thesauria re needed to matchdataand knowledge in external resources to the knowledgebase of the CPOE system (cf. Fig. 4, Table1) .
When analyzing the dischargeletters we found thatd osagei nformation is often incomplete andambiguous.According to the results of ourf ocus groups thisw as, however,n ot ac ritical weakness, and did not cause problems in generalp ractice. Moreover andm ore important for the general practitioner,t he results of ourq ualitative research revealed thatc linicians rarely use activei ngredients,a nd preferp rescribing brand names.Indeed allinterviewedrepresentatives of the departments in the hospital drug committeet hought that activei ngredients area lwayse itherm entioned in bracketsa fterthe brand name, or arementioned with firstp riority,w hich waso nly true in am inority of the cases when analyzed objectively.There areseveral ways to increase the useo fa ctivei ngredients in dailypractice, butthe least effortand training hours aree ncounteredi fastrategy is adopted wherebya ctivei ngredients and lectionofanappropriate drug for apatient is an important quality factor,because adverse reactions can be avoided and effectiveness can be improved. To meet theexpectations of allparties, thedrugrecommendationinadischarge lettershouldinclude theactiveingredient as well as examples for brand names. The activeingredient is important to knowto facilitate switches between therapeuticalternatives whichw ill also affect cost. But in most cases it will also be important to know corresponding brand names, becauseb rand names are specifically linkedtothe summary of product characteristics( SPC) that is approvedbythe local authorities. This statutory document is thelegal basis of prescribing and defines important conditions for thesafe use of adrug(e.g. approvedindications).Brand names are also thelinktoadditives, galenic information, and cost. Table1lists drug char- brand names areboth accepted, andifeither is missing, is automatically addedt ot he text. Without doubt, this is atask thatcan be readilya nd moree fficientlys olved by a computers ystem than by physicians in a hectic environment.
4.2L imitations of the Study
We weightedt he sample size according to the numbers of cases of each department andt herefore assume thatt he sample was representative. We did,h owever,o nlya nalyze dischargeletters of onemonth assuming thattheyreflect arathertypicalsituation forthis hospital.This mayhaveintroduced ab ias, buth ad the considerablea dvantage of being closelyl inked in time with corresponding interviews of physicians writing the letters andthosereceiving them.
Anotherpotential bias mayhavebeen introduced by selecting interviewp artners only from the hospitaldrugcommittee who mostlyw eres enior physicians andc onsultants.Wemighthaveobtaineddivergent results if we hadd rawn ar epresentative sample of interns or junior residents who mighthavehad moredirect insightinto the actualp rescribing habits. We preferred, however, to have interviewp artners from each department whoh avea no verviewo f allaspects of the drug prescription process in their department.
4.3P erspective
Forefficient cooperative careitisnecessary to improvet he interfaces for drug therapy between in-patient ando ut-patientc are. This could startwith astructured historyof the out-patient drug therapy at the time of admission. Reliable andcomprehensive information on previousd ruge xposure is necessaryf or being able to continue relevantdrugtherapy,and to avoid withdrawal syndromes andd rugi nteractions. Such information is also requiredifthe patientisto be returnedt op re-admission medication regimens afterd ischarge.E fforts toward a patient-centerede lectronic health record [24] [25] [26] , andi np articulart he function of electronic prescriptions [12, 27] on the
Conclusion
Documenting activei ngredients andb rand namesi np harmacotherapeutic recommendationsindischarge letters is currentlynot part of clinical practiceinGermany.Inmost cases drugs arer ecommended by their brandn ame. Ourr esults have shownt hat this cannot be avoided,e venw henanelectronic drug information platform is available,aslong as it is notfullyinterlinked with andintegrated in the process of writing discharge letters.
Experiences from othern ationsh ave shownt hats pecifying activei ngredients alone is also not sufficient to provide highquality pharmacotherapeutic recommendations. Therefore CPOE-systems should offers upporti np rescribing activei ngredients as well as brand names andd osage eHealth-Card for patientc arei nG ermany could maket his information available, althoughitwill notcover alldrugexposuresas longasitdoesnot include non-prescription drugs.Thorough information could not only influencepharmacotherapy during the hospital stay,b ut also could positivelyi mpact the utility of the recommendationsi nt he dischargeletter. Prescribingdivergent drugs can decrease both compliancea nd ease of handling for the patient, andt hus can increase costs. Up-to-nowvalid algorithmsto integratepreviously administereddrugs into therapy recommendationsare not available. Also,suggesting alternativedrugtherapies is difficult because there is no consensusas to whichd rugs can be regardeda st herapeutically equivalent. Bothshould be areas of future research relevant for efficient health careofhigh quality. The local CPOEinterface process contains alocalformulary which hastobemapped to the official brandcatalogue andknowledgeresources likecatalogueswith drugs thatshouldnot be administered to pregnantwomen.The localdecision support functions(CDS)processes patient dataand gives alerts using knowledge functions fromexternal decision support systems, for exampledosing forpatients with renal insufficiency.The prescription results have to be storedinalong-term archive with shared accessfor authorized partners and -ifavailable-inanelectronic health record (or at leastahealthcard).
schemes. Electronic supportfor pharmacotherapy in discharge letters could then become aquality factor for process quality in a hospital,with considerableinfluenceonthe outcome quality andc osts of cooperative patientcare.
